Masanori Abe, Hidetoshi Shiga, Hiroomi Tatsumi, Yoshihiro Endo, Yoshihiko Kikuchi, Yasushi Suzuki, Kent Doi, Taka-Aki Nakada, Hiroyuki Nagafuchi, Noriyuki Hattori, Nobuyuki Hirohashi, Takeshi Moriguchi, Osamu Yamaga, Osamu Nishida
BACKGROUND: The Japan Society for Blood Purification in Critical Care (JSBPCC) has reported survey results on blood purification therapy (BPT) for critically ill patients in 2005, 2009, and 2013. To clarify the current clinical status, including details of the modes used, treated diseases, and survival rate, we conducted this cohort study using data from the nationwide JSBPCC registry in 2018. METHODS: We analyzed data of 2371 patients who underwent BPT in the intensive care units of 43 facilities to investigate patient characteristics, disease severity, modes of BPTs, including the dose of continuous renal replacement therapy (CRRT) and hemofilters, treated diseases, and the survival rate for each disease...
2022: Renal replacement therapy